Our Management Team
Bernard Sagaert
Interim CEO
Bernard Sagaert
Bernard Sagaert is an Industrial Pharmacist with extensive operational experience in the pharmaceutical and life sciences industry. He has expertise in pharmaceutical authorizations, inspections and manufacturing and has an extensive operational background, both in companies as as consultant. He was a former QA & Supply Chain Director at Mylan in Belgium, and VP QA EMEAA at Sterigenics, a Sotera company.
Stefaan De Koker
VP Discovery
Stefaan De Koker
Stefaan is Principal Scientist with over 15 years of research experience in immunology, immuno-oncology, vaccine design and nucleic acid delivery. He has a publication track record of over >50 publications and is the key author of a number of patents.
Marina Cools
VP Clinical Development
Marina Cools
Marina is a virologist with over twenty years of experience in pharmaceutical R&D; from drug discovery to late stage clinical development. She has worked with biotech SMEs and large pharmaceutical companies.
Phil Challis
VP Product Development
Phil Challis
Phil has 30 years of experience in the Pharmaceutical and Biotech industry having worked for small SME’s, larger pharmaceutical companies and CDMO’s. He has broad experience in manufacture of biologicals and NCE’s with experience in transfer of processes from R&D, process development through clinical phases and process validation and commercial manufacture.
Michael Mulqueen
VP Business Development
Michael Mulqueen
Michael has over 30 years of experience in the Pharma and biotech industry, including 18 years in business development. He served as Head of Business Development & Licensing at Silence Therapeutics. He has held prior business development roles at Roche, Biotie Therapies and Synosia Therapeutics.
Dirk Van Broekhoven
VP Corporate Management
Dirk Van Broekhoven
Dirk has more than twenty-five years of experience as legal counsel in the healthcare industry. In addition to his general legal, he has specialized in intellectual property management and corporate development and licensing.
Bart Francken
Senior R&D Project and Portfolio Manager
Bart Francken
Bart has over 15 years of experience in R&D project and portfolio management in the biotech and pharma industry. Before joining eTheRNA he served as Project and Portfolio Manager in drug discovery and development at Galapagos.
Ronald Openshaw
Interim Head of Finance
Ronald Openshaw
Menu